BR100 Increased By (0.52%)
BR30 Increased By (0.49%)
KSE100 Increased By (0.46%)
KSE30 Increased By (0.58%)
BECO 5.67 Decreased By ▼ -0.06 (-1.05%)
BML 57.03 Decreased By ▼ -0.27 (-0.47%)
BOP 36.90 Increased By ▲ 0.13 (0.35%)
CNERGY 8.32 Decreased By ▼ -0.07 (-0.83%)
DCL 11.93 Decreased By ▼ -0.11 (-0.91%)
FCCL 58.70 Increased By ▲ 0.09 (0.15%)
FCSC 5.10 Increased By ▲ 0.09 (1.8%)
FFL 18.08 Increased By ▲ 0.14 (0.78%)
FNEL 1.26 No Change ▼ 0.00 (0%)
HUMNL 11.31 Decreased By ▼ -0.11 (-0.96%)
KEL 8.26 Decreased By ▼ -0.03 (-0.36%)
KOSM 6.57 Decreased By ▼ -0.05 (-0.76%)
MLCF 107.69 Decreased By ▼ -0.60 (-0.55%)
NBP 209.48 Increased By ▲ 3.44 (1.67%)
PACE 11.20 Increased By ▲ 0.03 (0.27%)
PAEL 45.54 Increased By ▲ 0.19 (0.42%)
PIAHCLA 30.33 Decreased By ▼ -0.44 (-1.43%)
PIBTL 18.87 Decreased By ▼ -0.19 (-1%)
PPL 248.61 Increased By ▲ 2.66 (1.08%)
PRL 36.30 Increased By ▲ 0.22 (0.61%)
PTC 73.75 Increased By ▲ 1.39 (1.92%)
SEARL 96.28 Decreased By ▼ -0.39 (-0.4%)
SSGC 31.43 Decreased By ▼ -0.24 (-0.76%)
TELE 9.23 Decreased By ▼ -0.04 (-0.43%)
THCCL 68.20 Increased By ▲ 0.39 (0.58%)
TPLP 11.60 Increased By ▲ 0.37 (3.29%)
TREET 25.78 Decreased By ▼ -0.11 (-0.42%)
TRG 67.40 Decreased By ▼ -0.44 (-0.65%)
WAVES 11.24 Increased By ▲ 0.26 (2.37%)
WTL 1.27 Decreased By ▼ -0.01 (-0.78%)
Editorials

Gene-editing tech could make people immune to flu, HIV in future

Vaccines for viral infections like flu are difficult to develop, but thanks to new emerging gene-editing technology
Published Updated

Vaccines for viral infections like flu are difficult to develop, but thanks to new emerging gene-editing technology, people could soon go immune to flu or even HIV.

Researchers at the Fred Hutchinson Cancer Research Center have developed a new technique for artificially creating advanced and longer-lasting antibodies by gene-editing the DNA of B cells – immune systems white blood cells responsible for creating antibodies.

As per Futurism, several traditional antibody treatments are only effective for a short time period; antibodies tend to break down rapidly, later requiring additional injections. According to scientists, their technique can ultimately allow doctors to overcome this hurdle since the new antibodies would only need to be injected once.

Chinese scientists clone gene-edited monkeys for disease research

The research published in the journal bioRxiv described that initial tests involved 15 mice and showed promising results, providing 82 days of protection against the respiratory syncytial virus (RSV) – a respiratory tract infection that can prove dangerous for children and adults both.

Moreover, according to New Scientist, despite gene-editing being a rapidly growing trend, scientists still need to prove the technique completely safe, which might take few years. But, according to the research, if the technology ever becomes treatment for humans in future, ‘thousands of hospital visits, disabilities, and death could be prevented each year’.

Copyright Business Recorder, 2019

Comments

Comments are closed for this article.